Accessibility Accessibility icon
CONSULTATION (303) 951-5829
Accent Image
New Study Finds Relief For Rosacea Sufferers

New Study Finds Relief For Rosacea Sufferers

July 25, 2011

A recent study in Dermatology Times remarked that people with Rosacea say the disease can negatively affect their workplace interactions and employment — even to the extent of being denied promotions.  In this survey of 1134 Rosacea patients by the National Rosacea Society, 60 percent of all people responding and 88 percent of those who reported severe symptoms said that the disorder had negatively impacted their workplace interactions.  And among those who reported severe symptoms, 51 percent said they had actually missed work because of their condition. 

Rosacea is a very common disorder resulting in redness and flushing to the face.  Most patients begin with a baseline of increased redness but may experience pronounced flushing when exposed to stimulating agents such as heat, alcohol, or even stress.  And while there is really no cure for Rosacea, the good news is that its symptoms can generally be treated very easily with minimal downtime. 

The initial starting point for treatment of Rosacea is good skincare.  And while effective anti-aging products and ingredients can be used, there should be a focus on gentleness since even the slightest amount of irritation can often produce dramatic flaring in a patient with Rosacea.  For our patients, we individualize a program that is gentle and something that will not irritate their skin long-term.  In addition, we have found good success with the SkinMedica CalmPlex product.  When used for at least 90 days, this topical has shown very good success at taming redness and inflammation with very little downside.  Since it is emollient, we encourage our patients to use a small amount of product and increase up as tolerated. 

In addition to good skincare, one of the staples of treating Rosacea is broadband light therapy.  This procedure (BBL) involves a few treatment sessions but is associated with minimal discomfort and almost no downtime. 

Why am I interested in treating Rosacea?  Because I have Rosacea!  And I have seen impressive improvement of my own facial redness by using SkinMedica CalmPlex and an occasional BBL treatment. 

While there is no actual cure for Rosacea, there are effective ways to treat its symptoms.  We look forward to working with you to achieve a red-free face!  Please call us at our Denver Plastic Surgery office for more information.

Visualize your NEW LOOK in 3D NOW

START NOW
Natrelle® Breast Implants
IMPORTANT SAFETY INFORMATION

Breast implants are not lifetime devices. The longer patients have them, the greater the chance they will develop complications, which may require more surgery. Breast implants have been associated with a cancer of the immune system called breast implant–associated anaplastic large cell lymphoma (BIA-ALCL). Some patients have died from BIA-ALCL. Patients have also reported a variety of systemic symptoms such as joint pain, muscle aches, confusion, chronic fatigue, autoimmune diseases, and others.

Natrelle® Breast Implants are for breast augmentation and revision surgery in women at least 22 years old for silicone-filled implants and women at least 18 years old for saline-filled implants.

You should not get breast implants if you currently have an active infection, untreated breast cancer or precancer, or are pregnant or nursing. Tell your doctor about any conditions you have, any medications you are taking, and any planned cancer treatments. Breast implantation is likely not a one-time surgery.

Having implants removed and not replaced may lead to permanent cosmetic changes of the breasts. Breast implants may affect breastfeeding. Gel implants may rupture without symptoms, so periodic imaging after surgery is recommended.

Key complications are reoperation, implant removal, implant rupture, implant deflation with saline-filled implants, and severe capsular contracture.

Talk to your doctor for more information.

The use of Natrelle® Breast Implants is restricted to licensed physicians who provide information to patients about the risks and benefits of breast implant surgery.

Visualize your
NEW LOOK in 3D NOW!

Start now
START NOW
Natrelle® Breast Implants
IMPORTANT SAFETY INFORMATION

Breast implants are not lifetime devices. The longer patients have them, the greater the chance they will develop complications, which may require more surgery. Breast implants have been associated with a cancer of the immune system called breast implant–associated anaplastic large cell lymphoma (BIA-ALCL). Some patients have died from BIA-ALCL. Patients have also reported a variety of systemic symptoms such as joint pain, muscle aches, confusion, chronic fatigue, autoimmune diseases, and others.

Breast implants are not lifetime devices. The longer patients have them, the greater the chance they will develop complications, which may require more surgery. Breast implants have been associated with a cancer of the immune system called breast implant–associated anaplastic large cell lymphoma (BIA-ALCL). Some patients have died from BIA-ALCL. Patients have also reported a variety of systemic symptoms such as joint pain, muscle aches, confusion, chronic fatigue, autoimmune diseases, and others.

Breast implants are not lifetime devices. The longer patients have them, the greater the chance they will develop complications, which may require more surgery. Breast implants have been associated with a cancer of the immune system called breast implant–associated anaplastic large cell lymphoma (BIA-ALCL). Some patients have died from BIA-ALCL. Patients have also reported a variety of systemic symptoms such as joint pain, muscle aches, confusion, chronic fatigue, autoimmune diseases, and others.

Breast implants are not lifetime devices. The longer patients have them, the greater the chance they will develop complications, which may require more surgery. Breast implants have been associated with a cancer of the immune system called breast implant–associated anaplastic large cell lymphoma (BIA-ALCL). Some patients have died from BIA-ALCL. Patients have also reported a variety of systemic symptoms such as joint pain, muscle aches, confusion, chronic fatigue, autoimmune diseases, and others.